US Broker Ratings

Fresenius Medical Care AG (FMS) Stock Analysis: Is There an 8.66% Upside for Investors?

Fresenius Medical Care AG (NYSE: FMS), a global leader in providing dialysis and related services, stands as a pivotal player in the healthcare sector, specifically within the medical care facilities..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 24.62% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the global healthcare sector, is one of Japan’s most renowned drug manufacturers, focusing on both specialty and generic pharmaceuticals. With a..

The Cigna Group (CI) Stock Analysis: Exploring a 20.83% Upside Potential

Investors eyeing the healthcare sector may find The Cigna Group (NYSE: CI) an intriguing candidate, given its strategic positioning and promising upside potential. With a market capitalization of $74.66 billion,..

Illumina, Inc. (ILMN) Stock Analysis: A Closer Look at Growth Potential and Market Position

Illumina, Inc. (ILMN), a prominent player in the Diagnostics & Research industry, stands at the forefront of genomic and genetic analysis solutions. With a market capitalization of $28.82 billion, Illumina..

Novartis AG (NVS) Stock Analysis: Navigating Healthcare’s Giant with a 4.16% Potential Upside

Novartis AG (NYSE: NVS), a powerhouse in the global healthcare sector, is a name that resonates with both innovation and financial solidity. Headquartered in Basel, Switzerland, Novartis is a key..

Sanofi (SNY) Stock Analysis: Exploring a 22.88% Upside Potential for Investors

Sanofi (SNY), a leading player in the healthcare sector, is renowned for its innovative solutions in drug manufacturing and therapeutic advancements. Headquartered in Paris, France, Sanofi is a titan in..

Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Innovator with Modest Upside and Resilient Performance

Revvity, Inc. (NASDAQ: RVTY), formerly known as PerkinElmer, Inc., is making waves in the healthcare sector with its innovative solutions in diagnostics and research. With a market capitalization of $13.04..

Cencora, Inc. (COR) Stock Analysis: Exploring the 18.73% Potential Upside in Healthcare Distribution

Cencora, Inc. (NYSE: COR), a heavyweight in the healthcare sector with a substantial market capitalization of $59.89 billion, is capturing the attention of investors with its solid performance and promising..

DaVita Inc. (DVA) Stock Analysis: A Strong ROE and 21% Potential Upside

DaVita Inc. (DVA), a major player in the healthcare sector, stands out in the medical care facilities industry with its focus on providing essential kidney dialysis services. With a market..

STERIS plc (Ireland) (STE)

⚠️ No article content returned.

..

Bristol-Myers Squibb Company (BMY): Investor Outlook on a Healthcare Giant with a Promising 3.73% Upside

Bristol-Myers Squibb Company (NYSE: BMY) stands as a formidable player in the healthcare sector, particularly within the drug manufacturing industry. With a substantial market capitalization of $130.39 billion, this U.S.-based..

Medtronic plc (MDT) Stock Analysis: A 7.86% Potential Upside with Strong Buy Ratings

Investors eyeing opportunities in the healthcare sector may find Medtronic plc (MDT) an intriguing prospect. With a potential upside of 7.86% and a robust consensus of buy ratings from analysts,..

Labcorp Holdings Inc. (LH) Stock Analysis: A Healthcare Giant with a 6.17% Upside Potential

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the Healthcare sector, is capturing investor attention with its robust performance metrics and promising growth potential. As a leader in Diagnostics..

Insulet Corporation (PODD) Stock Analysis: Exploring a 19.93% Potential Upside Amid Strong Revenue Growth

Insulet Corporation (NASDAQ: PODD), a leading name in the medical devices industry, continues to capture investor interest with its innovative insulin delivery systems. The company’s flagship product, the Omnipod platform,..

Insmed Incorporated (INSM) Stock Analysis: 61.67% Potential Upside Amidst Robust Revenue Growth

Navigating the complex landscape of biotechnology investments can be daunting, yet Insmed Incorporated (NASDAQ: INSM) emerges as a compelling player due to its promising growth prospects and significant potential upside...

Incyte Corporation (INCY) Stock Analysis: Exploring 37.7% Revenue Growth and a Promising Pipeline

Incyte Corporation (NASDAQ: INCY), a stalwart in the biotechnology sector, continues to captivate investors with its robust revenue growth and a promising array of therapeutic products. With a market capitalization..

Veeva Systems Inc. (VEEV) Stock Analysis: Navigating the Healthcare Cloud with a $39.6 Billion Market Cap

Veeva Systems Inc. (NYSE: VEEV) is a formidable player in the healthcare sector, focusing on health information services through its robust suite of cloud-based software solutions. With a market capitalization..

Quest Diagnostics (DGX) Investor Outlook: Analyzing Growth and Potential Upside

Investors seeking a solid opportunity in the healthcare sector may find Quest Diagnostics Incorporated (NYSE: DGX) an intriguing proposition. As a leader in the diagnostics and research industry, Quest Diagnostics..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Strong Buy Ratings and Growth Potential in the Healthcare Sector

Thermo Fisher Scientific Inc (NYSE: TMO), a leading player in the Healthcare sector, continues to impress investors with its robust performance and promising outlook. As a titan in the Diagnostics..

Tenet Healthcare Corporation (THC) Stock Analysis: A Strong Buy with 5.26% Upside

Tenet Healthcare Corporation (NYSE: THC), a key player in the U.S. healthcare sector, presents an intriguing opportunity for investors seeking exposure to the medical care facilities industry. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds